| Variable | Category | Obs | Univariate analysis; OS | Multivariate analysis; OS | HR | P | 95%CI | HR | P | 95%CI |
| Gender | M/F | 48/38 | 0.747 | 0.194 | 0.481-1.160 | | | | Age | <64/≥64 | 40/46 | 1.709 | 0.017 | 1.102-2.652 | 1.478 | 0.097 | 0.932-2.344 | PLT, 109/L | <258.67/≥258.67 | 64/22 | 0.652 | 0.090 | 0.397-1.069 | | | | PDW, fL | <17.99/>=17.99 | 64/22 | 0.916 | 0.726 | 0.560-1.497 | | | | MPV, fL | <12.46/>=12.46 | 64/22 | 1.24 | 0.388 | 0.761- 2.021 | | | | LYM, 109/L | <1.5/>=1.5 | 64/22 | 0.636 | 0.075 | 0.387-1.046 | | | | NEU, 109/L | <7.12/>=7.12 | 64/22 | 1.160 | 0.553 | 0.711-1.891 | | | | PLR | <240.18/>=240.18 | 66/20 | 0.940 | 0.814 | 0.560-1.577 | | | | NLR | <6.17/>=6.17 | 65/21 | 1.820 | 0.020 | 1.098-3.018 | 1.457 | 0.178 | 0.843-2.517 | APTT, s | <30.8/≥30.8 | 64/22 | 0.868 | 0.577 | 0.529-1.426 | | | | PT, s | <12.3/≥12.3 | 64/22 | 1.670 | 0.041 | 1.020-2.733 | 1.829 | 0.036 | 1.042-3.212 | INR | <1.07/≥1.07 | 64/22 | 1.670 | 0.041 | 1.020-2.733 | | | | FIB, g/l | <4.49/≥4.49 | 64/22 | 1.393 | 0.196 | 0.843-2.304 | | | | TT, s | <18.75/≥18.75 | 65/21 | 0.853 | 0.528 | 0.519-1.399 | | | | DD, ug/ml | <1.11/≥1.11 | 63/21 | 1.263 | 0.341 | 0.781-2.043 | | | | ALB, g/L | <35/≥35 | 38/48 | 0.618 | 0.032 | 0.397-0.960 | 1.238 | 0.459 | 0.704-2.176 | CRP, mg/L | <10/≥10 | 25/61 | 1.304 | 0.272 | 0.812-2.092 | | | | GPS | 0/1-2 | 19/67 | 1.198 | 0.494 | 0.714-2.011 | | | | CA199, U/ml | <37/>=37 | 28/58 | 1.295 | 0.269 | 0.818-2.050 | | | | CA125, U/ml | <36.49/≥36.49 | 59/27 | 0.970 | 0.896 | 0.611-1.537 | | | | CEA, ng/ml | <5.1/≥5.1 | 57/29 | 1.24 | 0.350 | 0.79-1.96 | | | | Differentiation | Middle-High/Low | 57/29 | 3.382 | 0.001 | 2.033-5.628 | 3.046 | 0.001 | 1.667-5.566 | Lymph | (+)/(-) | 39/47 | 0.712 | 0.127 | 0.459-1.102 | | | | Nerve | (+)/(-) | 60/26 | 0.756 | 0.240 | 0.475-1.205 | | | | Stage | I-II/III-IVA | 62/24 | 1.840 | 0.015 | 1.126-3.008 | 1.621 | 0.062 | 0.975-2.695 |
|
|
Obs, observation, PLT, platelet count, PDW, platelet distribution width, MPV, mean platelet volume, LYM, lymphocyte count NEU, neutrophil count, PLR, platelet-lymphocyte ratio, NLR, neutrophil-lymphocyte ratio, ALB, albumin, CRP, C-reactive protein, GPS, Glasgow Prognostic Score, APTT, activated partial thromboplastin time, PT, prothrombin time, INR, international normalized ratio, FIB, fibrinogen, TT, thrombin time, DD: D-dimer, Lymph: lymph node metastasis, and Nerve, nerve invasion. OS, overall survival and RFS, recurrence-free survival.
|